Teva Pharmaceutical Industries
TEVA
39.18
+0.05
+0.13%
Teva Pharmaceutical Industries
US · TEVA
#471 by market cap
Listed 1970
39.18
+0.05
+0.13%
Live - 5344 symbols - heartbeat 204s ago
· 2026-10-08 08:25
Pre-market
38.81
-0.94%
After-hours
39.18
0.00%
Overnight
38.80
-0.97%
- Market cap
- 45.70B
- P/E (TTM)i
- 65.30
- P/Bi
- 5.89
- EPSi
- 1.21
- Div yieldi
- 0.00%
- 52W posi
- 93%
Reader sentiment
Are you bullish or bearish on TEVA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 5 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 77.53% -0.07pp
- Institutions
- 843 -5
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund54.66%
Public Company6.49%
Sovereign Wealth Fund6.06%
Hedge Fund4.55%
Government Pension Fund2.03%
Family Office/Trust1.85%
Private Company1.44%
Individual/Insider0.43%
Insurance Company0.18%
Other22.33%
Top holders as of 2026-06-30
Norges Bank Investment Management
6.01% · 70.08M sh
BlackRock
5.97% · 69.59M sh
Phoenix Investments & Finances Ltd
5.35% · 62.32M sh
Harel Insurance Investments & Financial Services Ltd
4.18% · 48.76M sh
Vanguard Capital Management, LLC
3.68% · 42.87M sh
WCM Investment Management
3.55% · 41.32M sh
Clal Financial Management Ltd
3.48% · 40.60M sh
Migdal Mutual Funds Ltd.
3.46% · 40.37M sh
Menora Mivtachim Provident Funds
3.42% · 39.85M sh
FMR
2.31% · 26.89M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 26 buys · 24 sells
| Name | Role | Stake |
|---|---|---|
| Amir Elstein | Independent Director | 0.18% |
| Richard Francis | Chief Executive Officer | 0.10% |
| Sol Barer | Independent Chairperson | 0.04% |
| Eric Hughes | Executive VP of Global R&D and Chief Medical Officer | 0.01% |
| Gerald Lieberman | Independent Director | 0.01% |
| Rosemary Crane | Independent Director | 0.01% |
| Perry Nisen | Independent Director | 0.01% |
| Roberto Mignone | Independent Director | 0.01% |
| Ronit Satchi-Fainaro | Independent Director | 0.01% |
| Mark Sabag | Executive Vice President of International Markets Commercial | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-17 | Bridger Management LLC | -- | Intent to Sell (Form 144) | -367,600 | $39.19 |
| 2026-09-17 | Brian Savage | Interim Chief Legal Officer | Open Market Disposition | -2,839 | $38.70–39.15 |
| 2026-09-17 | Brian Savage | Interim Chief Legal Officer | Derivative Exercise and Sale | -4,503 | $34.70–38.69 |
| 2026-08-20 | Ronit Satchi-Fainaro | Independent Director | Private Disposition | -415 | $37.25 |
| 2026-08-20 | Amir Weiss | Chief Accounting Officer | Private Disposition | -6,945 | $37.61 |
| 2026-08-20 | Amir Weiss | Chief Accounting Officer | Derivative Exercise and Sale | -2,500 | $19.61–37.63 |
| 2026-08-16 | Evan Lippman | Executive Vice President, Business Development | Automatic Disposition | -18,600 | $36.57 |
| 2026-08-04 | Tal Zaks | Independent Director | Private Disposition | -17 | $34.87 |
| 2026-08-02 | Eric Hughes | Executive VP of Global R&D and Chief Medical Officer | Derivative Exercise and Sale | -25,578 | $34.88 |
| 2026-08-02 | Eric Hughes | Executive VP of Global R&D and Chief Medical Officer | Derivative Exercise and Retained | +27,166 | -- |
| 2026-08-02 | Placid Jover | Executive VP & CHRO | Derivative Exercise and Sale | -12,827 | $34.88 |
| 2026-06-17 | Matthew Shields | Officer | Private Disposition | -9,989 | $32.19 |
| 2026-06-10 | Eliyahu Kalif | Chief Financial Officer | Automatic Disposition | -106,563 | $34.10 |
| 2026-06-04 | Sol Barer | Independent Chairperson | Derivative Exercise and Retained | +21,739 | -- |
| 2026-06-04 | Amir Elstein | Independent Director | Derivative Exercise and Retained | +14,492 | -- |
| 2026-06-04 | Gerald Lieberman | Independent Director | Derivative Exercise and Retained | +14,492 | -- |
| 2026-06-04 | Roberto Mignone | Independent Director | Derivative Exercise and Retained | +14,492 | -- |
| 2026-06-04 | Rosemary Crane | Independent Director | Derivative Exercise and Retained | +14,492 | -- |
| 2026-06-04 | Richard Francis | Chief Executive Officer | Derivative Exercise and Sale | -6,153 | $34.35 |
| 2026-06-04 | Richard Francis | Chief Executive Officer | Derivative Exercise and Retained | +6,890 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:25:10 · For reference only, not investment advice and not tailored to your situation.